User profiles for Sara Rolandsson Enes

Sara Rolandsson Enes

Lund University
Verified email at med.lu.se
Cited by 714

Functional role of glycosaminoglycans in decellularized lung extracellular matrix

FE Uhl, F Zhang, RA Pouliot, JJ Uriarte, SR Enes… - Acta biomaterialia, 2020 - Elsevier
Despite progress in use of decellularized lung scaffolds in ex vivo lung bioengineering
schemes, including use of gels and other materials derived from the scaffolds, the detailed …

[HTML][HTML] MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSC

S Rolandsson Enes, A Andersson Sjöland, I Skog… - Scientific reports, 2016 - nature.com
Mesenchymal stromal cells (MSC) are multipotent cells with regenerative and immune-modulatory
properties. Therefore, MSC have been proposed as a potential cell-therapy for …

[HTML][HTML] The MSC-EV-microRNAome: a perspective on therapeutic mechanisms of action in sepsis and ARDS

…, M Lopes-Pacheco, K English, S Rolandsson Enes… - Cells, 2024 - mdpi.com
Mesenchymal stromal cells (MSCs) and MSC-derived extracellular vesicles (EVs) have
emerged as innovative therapeutic agents for the treatment of sepsis and acute respiratory …

Concise review: the bystander effect: mesenchymal stem cell-mediated lung repair

UB Savukinas, SR Enes, AA Sjöland… - Stem …, 2016 - academic.oup.com
Mesenchymal stem or stromal cells (MSCs), a heterogeneous subset of adult stem/progenitor
cells, have surfaced as potential therapeutic units with significant clinical benefit for a wide …

Lung inflammatory environments differentially alter mesenchymal stromal cell behavior

SC Abreu, S Rolandsson Enes… - … of Physiology-Lung …, 2019 - journals.physiology.org
Mesenchymal stromal (stem) cells (MSCs) are increasingly demonstrated to ameliorate
experimentally induced lung injuries through disease-specific anti-inflammatory actions, thus …

[HTML][HTML] hLMSC secretome affects macrophage activity differentially depending on lung-mimetic environments

…, I Almendros, J Otero, R Farré, S Rolandsson Enes… - Cells, 2022 - mdpi.com
Mesenchymal stromal cell (MSC)-based therapies for inflammatory diseases rely mainly on
the paracrine ability to modulate the activity of macrophages. Despite recent advances, there …

[HTML][HTML] Quantitative proteomic characterization of lung-MSC and bone marrow-MSC using DIA-mass spectrometry

S Rolandsson Enes, E Åhrman, A Palani, O Hallgren… - Scientific Reports, 2017 - nature.com
Mesenchymal stromal cells (MSC) are ideal candidates for cell therapies, due to their
immune-regulatory and regenerative properties. We have previously reported that lung-derived …

[HTML][HTML] The inflammatory lung microenvironment; a key mediator in MSC licensing

H Dunbar, DJ Weiss, S Rolandsson Enes, JG Laffey… - Cells, 2021 - mdpi.com
Recent clinical trials of mesenchymal stromal cell (MSC) therapy for various inflammatory
conditions have highlighted the significant benefit to patients who respond to MSC …

Healthy versus inflamed lung environments differentially affect mesenchymal stromal cells

SR Enes, TH Hampton, J Barua… - European …, 2021 - Eur Respiratory Soc
Background Despite increased interest in mesenchymal stromal cell (MSC)-based cell
therapies for acute respiratory distress syndrome (ARDS), clinical investigations have not yet …

[HTML][HTML] Harnessing the ECM microenvironment to ameliorate mesenchymal stromal cell-based therapy in chronic lung diseases

…, E Tykesson, S Rolandsson Enes… - Frontiers in …, 2021 - frontiersin.org
It is known that the cell environment such as biomechanical properties and extracellular
matrix (ECM) composition dictate cell behaviour including migration, proliferation, and …